What happens when NSAIDs injure the small bowel and cause hidden bleeding, ulcers, protein loss, or diaphragm-like strictures beyond the reach of routine EGD?
Linda’s path through medication review, small-bowel diagnosis, treatment, safer pain planning, and follow-up
Your guardians. GastroDoxs GutGuardians™ is our team of board-certified gastroenterologists - a physician-led defense force of specialists, systems, and solution pathways working together to protect, detect, solve, and defend your digestive health through expert GI evaluation, advanced diagnostic screening, and endoscopic evaluation - commanded from your first concern to your last follow-up, and every critical stage in between.
A 69-year-old retired ranch-office administrator navigating NSAID enteritis
Linda had years of NSAID exposure for osteoarthritis and developed recurrent episodes of cramping abdominal pain, bloating, nausea, and vomiting.
CT enterography showed short multifocal small-bowel narrowings with intermittent upstream dilation, while routine endoscopy could not reach the involved segments.
Because capsule retention was a concern, the team avoided routine capsule ingestion until luminal patency had been assessed.
Her Brookshire journey focused on recognizing NSAID diaphragm disease, stopping the causative medicines, and coordinating endoscopic or surgical treatment of fixed obstructive strictures.
The narrowing was not a typical tumor or Crohn’s stricture. Years of NSAID injury had produced thin diaphragm-like rings in the small bowel.
Linda’s earliest episodes resolved with bowel rest and were initially labeled nonspecific obstruction.
The recurrent pattern and long NSAID history raised concern for medication-related stricturing.
Thin diaphragm-like stenoses can be difficult to detect on routine studies because the bowel may look nearly normal between narrowed rings.
The final management depended on whether the strictures could be treated endoscopically or required surgery.
The turning point came when Linda understood that the small-bowel injury needed to be linked to medication exposure, lesion pattern, competing diagnoses, and complication risk.
Linda assumed stopping NSAIDs would immediately reopen the narrowed bowel.
The GI team explained that active mucosal injury can improve after withdrawal, but established fibrotic diaphragms may not regress.
Capsule endoscopy was approached cautiously because a retained capsule could become trapped behind a stricture.
Enterography and advanced enteroscopy helped define the anatomy.
Recurrent obstruction or nontraversable strictures created a surgical decision rather than a medication-only plan.
The plan had to establish whether NSAIDs truly explained the small-bowel findings, determine whether bleeding or obstruction was present, and create a workable alternative pain or cardiovascular strategy.
The Brookshire team documented pain, vomiting, distension, bowel movements, prior admissions, and decompression history.
Long-term diclofenac, naproxen, aspirin, and other NSAID exposure was reconstructed.
Patency testing or imaging was used before capsule evaluation when retention risk was meaningful.
Advanced endoscopy and surgery reviewed whether dilation, stricturoplasty, or resection was most appropriate.
GastroDoxs can review NSAID exposure, iron-deficiency anemia, occult bleeding, diarrhea, low albumin, capsule findings, enterography, stricture risk, and safer medication options.
The pathway moved from anemia, diarrhea, pain, or obstruction to NSAID exposure review, small-bowel testing, withdrawal of the causative medicine, and treatment of complications.
Linda’s earliest episodes resolved with bowel rest and were initially labeled nonspecific obstruction.
Review NSAID enteritis →The recurrent pattern and long NSAID history raised concern for medication-related stricturing.
Review abdominal pain →Patency testing or imaging was used before capsule evaluation when retention risk was meaningful.
Review capsule endoscopy →Further NSAID exposure was avoided whenever clinically feasible.
Schedule Brookshire follow-up →The pathway depends on NSAID exposure, bleeding, anemia, diarrhea, protein loss, suspected stricture, obstruction risk, and whether Crohn’s disease or another small-bowel disorder remains plausible.
The Brookshire team documented pain, vomiting, distension, bowel movements, prior admissions, and decompression history.
Long-term diclofenac, naproxen, aspirin, and other NSAID exposure was reconstructed.
Patency testing or imaging was used before capsule evaluation when retention risk was meaningful.
Further NSAID exposure was avoided whenever clinically feasible.
Endoscopic balloon dilation was considered for short, benign, reachable diaphragms.
Suspected small-bowel stricture changes capsule-endoscopy safety. Persistent vomiting, marked distension, heavy bleeding, or severe pain requires urgent evaluation.
NSAID dose and duration, lesion distribution, bleeding, anemia, protein loss, stricture risk, imaging, capsule findings, pathology, and competing diagnoses are interpreted together.
Chronic NSAID injury can produce thin concentric fibrotic strictures that narrow the small-bowel lumen.
Cramping, post-meal bloating, nausea, vomiting, weight loss, and episodic inability to pass stool or gas can occur.
Known or suspected small-bowel strictures should prompt patency assessment or cross-sectional imaging before capsule endoscopy.
Stopping the drug prevents further injury but does not guarantee reversal of established scar tissue.
Balloon dilation or resection is selected according to number, location, accessibility, severity, and complication risk.
The consultation connected medication exposure with the exact small-bowel consequence and the safest diagnostic and treatment sequence.
The Brookshire team documented pain, vomiting, distension, bowel movements, prior admissions, and decompression history.
Long-term diclofenac, naproxen, aspirin, and other NSAID exposure was reconstructed.
Stricture number, length, wall features, upstream dilation, ischemia, and alternative causes were assessed.
Patency testing or imaging was used before capsule evaluation when retention risk was meaningful.
Advanced endoscopy and surgery reviewed whether dilation, stricturoplasty, or resection was most appropriate.
Treatment removes ongoing NSAID injury when possible, corrects bleeding or nutritional consequences, and treats established strictures or complications separately.
Further NSAID exposure was avoided whenever clinically feasible.
Bowel rest, IV hydration, electrolyte correction, decompression, and serial examination were used according to severity.
Endoscopic balloon dilation was considered for short, benign, reachable diaphragms.
Persistent obstruction, multiple inaccessible strictures, perforation, or diagnostic uncertainty prompted surgical management.
Pain treatment was redesigned to reduce recurrence risk.
Persistent vomiting, severe distension, inability to pass gas, fever, or rigid abdominal pain required emergency care.
NSAID enteropathy may require gastroenterology, pain management, cardiology, advanced endoscopy, nutrition, hematology, or surgery depending on the complication.
The Brookshire team documented pain, vomiting, distension, bowel movements, prior admissions, and decompression history.
Patency testing or imaging was used before capsule evaluation when retention risk was meaningful.
Advanced endoscopy and surgery reviewed whether dilation, stricturoplasty, or resection was most appropriate.
Endoscopic balloon dilation was considered for short, benign, reachable diaphragms.
Stable care can include medication-risk review, iron and nutrition monitoring, small-bowel test interpretation, and coordination with pain, cardiology, advanced endoscopy, or surgery when needed.
Kingsland Crossing, 407 North Turnberry Lane, Brookshire, TX 77423
Tuesday and Thursday 7:00 AM to 7:00 PM
Brookshire, Fulshear, Pattison, Royal, west Katy, and nearby communities
North Turnberry Lane and the I-10 corridor
Coverage may differ for GI consultation, CBC and iron studies, capsule endoscopy, patency capsule, CT/MR enterography, device-assisted enteroscopy, endoscopic dilation, and surgery.
Include over-the-counter and prescription drugs, combination medicines, dose, frequency, and duration.
Provide CBC, ferritin, iron studies, albumin, weight trend, and transfusion history.
Capsule, enterography, EGD, colonoscopy, enteroscopy, and prior operative reports can change the next step.
Arthritis, cardiovascular disease, chronic pain, and other indications affect whether the medicine can safely be stopped.
The decision matched lesion type, bleeding or obstruction severity, NSAID necessity, alternative diagnoses, and the consequences of continued exposure.
Chronic NSAID injury can produce thin concentric fibrotic strictures that narrow the small-bowel lumen.
Cramping, post-meal bloating, nausea, vomiting, weight loss, and episodic inability to pass stool or gas can occur.
Patency testing or imaging was used before capsule evaluation when retention risk was meaningful.
Further NSAID exposure was avoided whenever clinically feasible.
NSAID small-bowel injury can look very different depending on whether the dominant problem is bleeding, inflammation, protein loss, or fibrosis.
Capsule endoscopy may show reddened folds, erosions, denuded areas, or ulcers causing pain or occult bleeding.
Best for: Patients with unexplained anemia or small-bowel symptoms after routine endoscopy
Limitations: Findings can overlap with Crohn’s disease and other enteropathies
Takeaway: Interpret lesions with medication exposure and the full differential
Chronic small-bowel blood loss can present mainly as falling ferritin or hemoglobin.
Best for: Patients with unexplained iron deficiency after upper and lower GI evaluation
Limitations: Other small-bowel bleeding sources must be excluded
Takeaway: The absence of visible blood does not exclude NSAID injury
Diffuse inflammation can contribute to enteric protein loss and hypoalbuminemia.
Best for: Patients with edema, low albumin, diarrhea, and compatible NSAID exposure
Limitations: Liver, kidney, heart, nutrition, and other enteropathies must be excluded
Takeaway: Treat the cause, not only the edema
Fibrotic ring-like narrowing can cause recurrent partial or complete small-bowel obstruction.
Best for: Long-term NSAID users with obstructive symptoms and short multifocal stenoses
Limitations: Capsule retention risk and need for intervention are higher
Takeaway: Assess patency before capsule and treat fixed narrowing separately
Heavy bleeding, obstruction, perforation, severe anemia, or dehydration can turn a chronic medication injury into an emergency.
How the NSAID-induced small-bowel diaphragm disease causing recurrent partial obstruction after years of diclofenac and naproxen use journey changed medication use, small-bowel symptoms, and follow-up
Further NSAID exposure was avoided whenever clinically feasible.
Bowel rest, IV hydration, electrolyte correction, decompression, and serial examination were used according to severity.
Pain treatment was redesigned to reduce recurrence risk.
Linda returned to daily responsibilities with a clearer understanding of which pain or cardiovascular medicines carried small-bowel risk and why medication changes needed coordination.
The patient also knew that new bleeding, severe pain, vomiting, or distension required prompt reassessment.
The narrowing was not a typical tumor or Crohn’s stricture. Years of NSAID injury had produced thin diaphragm-like rings in the small bowel.
This Brookshire patient journey is an educational composite illustrating NSAID-induced small-bowel diaphragm disease causing recurrent partial obstruction after years of diclofenac and naproxen use. It does not represent a specific patient. NSAID enteritis can cause small-bowel erosions, ulcers, occult or overt bleeding, protein loss, diaphragm-like strictures, obstruction, and rarely perforation. Diagnosis requires medication review and exclusion of other small-bowel disorders. Stopping an NSAID or aspirin may be unsafe when it is medically essential, so medication changes should be coordinated with the prescribing clinician. Heavy bleeding, severe pain, persistent vomiting, marked distension, fainting, or fever with worsening illness requires prompt medical assessment.
Answers about small-bowel NSAID injury, anemia, capsule endoscopy, diaphragm disease, Crohn’s mimics, aspirin, misoprostol, PPIs, and urgent warning signs
NSAID enteritis is injury to the small intestine caused by nonsteroidal anti-inflammatory drugs such as ibuprofen, naproxen, diclofenac, or aspirin. It can produce erosions, ulcers, bleeding, protein loss, strictures, and rarely perforation.
GastroDoxs provides planned GI consultation at 407 North Turnberry Lane, Brookshire, TX 77423. Published office hours are Tuesday and Thursday, 8:00 AM to 5:00 PM.
Many patients have few symptoms. Others develop abdominal pain, diarrhea, iron-deficiency anemia, occult or overt bleeding, low albumin, weight loss, or obstructive symptoms.
Diagnosis uses medication history plus exclusion of competing causes and may involve capsule endoscopy, CT or MR enterography, device-assisted enteroscopy, laboratory testing, or surgery depending on the presentation.
It is a rare complication in which thin fibrotic ring-like strictures form in the small bowel and can cause partial or complete obstruction.
Capsule endoscopy is useful for mucosal lesions and obscure small-bowel bleeding, but suspected strictures should be assessed first because the capsule can become retained.
When medically possible, stopping the causative NSAID is foundational. Iron, nutrition, bleeding treatment, alternative pain therapy, and treatment of strictures are added according to the problem.
Misoprostol has evidence for healing aspirin-associated small-bowel ulcers in selected patients who must continue aspirin, but it is not a universal treatment and can cause diarrhea or cramping.
Yes. Both can cause ileitis, erosions, ulcers, bleeding, and strictures, so medication exposure, pathology, imaging, chronicity, and response after NSAID withdrawal matter.
Seek urgent care for heavy bleeding, black tarry stool with weakness, severe pain, persistent vomiting, marked distension, inability to pass gas or stool, fainting, or fever with worsening illness.
Explore related condition, symptom, and procedure guides connected with NSAID enteropathy.
Review causes, bleeding, ulcers, protein loss, diaphragm disease, diagnosis, and treatment.
Condition Guide →Review GI causes of chronic blood loss and when small-bowel evaluation is considered.
Anemia Guide →Understand vomiting, distension, cramping, and urgent evaluation of obstructive symptoms.
Obstruction Guide →Learn how capsule endoscopy evaluates small-bowel mucosal disease and bleeding.
Capsule Guide →Arrange stable review of NSAID exposure, anemia, capsule findings, enterography, and small-bowel complications.
Book Brookshire Appointment →Document every prescription and over-the-counter NSAID or aspirin, dose, duration, indication, and combination use.
Determine whether the dominant issue is occult bleeding, ulceration, diarrhea, protein loss, stricture, or obstruction.
Use capsule endoscopy for mucosal disease when appropriate and enterography or patency assessment when narrowing is suspected.
Further NSAID exposure was avoided whenever clinically feasible.
Endoscopic balloon dilation was considered for short, benign, reachable diaphragms.
Persistent vomiting, severe distension, inability to pass gas, fever, or rigid abdominal pain required emergency care.
GastroDoxs can review NSAID exposure, iron-deficiency anemia, occult bleeding, low albumin, capsule findings, enterography, stricture risk, and safer medication strategies.